Filing Details
- Accession Number:
- 0000899866-14-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 19:56:52
- Reporting Period:
- 2014-02-03
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 19:56:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457477 | David Hallal | C/O Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Disposition | 2014-02-03 | 729 | $157.14 | 108,220 | No | 4 | S | Direct | |
Common Stock, Par Value $.0001 Per Share | Disposition | 2014-02-04 | 2,390 | $153.63 | 105,830 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.